CVS CVS Health
NYSE · SEC CIK 64803 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $323.70M 2 sales by 2 insiders
- Filings on record
- 285 since 2021-08-05, latest 2026-06-29 15:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ROBBINS LARRY | Dir | — | $317.47M |
| Mandadi Tilak | EVP, Chief Exp, Tech Off | — | $6.23M |
| Shah Prem S | EVP, Group Pres | — | — |
| Newman Brian | EVP, CFO | — | — |
| Clark James David | SVP, Cont, Chief Acct Off | — | — |
| Balser Jeffrey R. | Dir | — | — |
| Compton-Phillips Amy | EVP, Chief Medical Off | — | — |
| Shulman Douglas H. | Dir | — | — |
| CAPOZZI HEIDI B | EVP, CHRO | — | — |
| Khichi Samrat S. | EVP, GC, CPO | — | — |
Transactions 264
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-16 | CVS | KIRBY J SCOTT | Dir | A - Grant | $57.52 | +2,912 | 5,633 | +107% | +$167.5K | |
| 2024-05-17 | 2024-05-16 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $57.52 | +2,314 | 2,314 | New | +$133.1K | |
| 2024-05-17 | 2024-05-16 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $57.52 | +2,347 | 34.5K | +7% | +$135.0K | |
| 2024-05-17 | 2024-05-16 | CVS | Balser Jeffrey R. | Dir | A - Grant | $57.52 | +2,184 | 7,277 | +43% | +$125.6K | |
| 2024-05-17 | 2024-05-16 | CVS | Mahoney Michael F | Dir | A - Grant | $57.52 | +2,184 | 4,001 | +120% | +$125.6K | |
| 2024-05-17 | 2024-05-16 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $57.52 | +2,314 | 31.8K | +8% | +$133.1K | |
| 2024-05-17 | 2024-05-16 | CVS | BROWN C DAVID II | Dir | A - Grant | $57.52 | +2,314 | 121.4K | +2% | +$133.1K | |
| 2024-05-02 | 2024-05-02 | CVS | Mahoney Michael F | Dir | P - Purchase | $54.49 | +9,181 | 9,356 | +5,246% | +$500.3K | |
| 2024-05-02 | 2024-05-02 | CVS | LUDWIG EDWARD J | Dir | P - Purchase | $53.88 | +1,000 | 21.6K | +5% | +$53.9K | |
| D | 2024-04-03 | 2024-04-01 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | $79.56 | +6,913 | 23.7K | +41% | +$550.0K |
| DM | 2024-04-03 | 2024-04-01 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | F - Tax | $79.56 | -2,298 | 12.0K | -16% | -$182.8K |
| DM | 2024-04-03 | 2024-04-01 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | F - Tax | $79.56 | -7,892 | 47.3K | -14% | -$627.9K |
| D | 2024-04-03 | 2024-04-01 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | A - Grant | $0.00 | +15.1K | 37.1K | +69% | $0 |
| 2024-04-03 | 2024-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $79.56 | +10.7K | 15.1K | +241% | +$849.9K | |
| M | 2024-04-03 | 2024-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $79.56 | -3,004 | 9,592 | -24% | -$239.0K |
| 2024-04-03 | 2024-04-01 | CVS | Joyner J. David | EVP, Pres-PharmacyServices | A - Grant | $0.00 | +28.3K | 44.2K | +177% | $0 | |
| D | 2024-04-03 | 2024-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $79.56 | -62.0K | 74.7K | -45% | -$4.93M |
| D | 2024-04-03 | 2024-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $79.56 | +45.2K | 45.2K | New | +$3.60M |
| D | 2024-04-03 | 2024-04-01 | CVS | COWHEY THOMAS F. | EVP, CFO | F - Tax | $79.56 | -1,719 | 35.6K | -5% | -$136.8K |
| D | 2024-04-03 | 2024-04-01 | CVS | COWHEY THOMAS F. | EVP, CFO | A - Grant | $0.00 | +15.1K | 48.0K | +46% | $0 |
| D | 2024-04-03 | 2024-04-01 | CVS | Kane Brian A | EVP, Pres, Aetna | A - Grant | $0.00 | +12.6K | 12.6K | New | $0 |
| D | 2024-04-03 | 2024-04-01 | CVS | Havanec Laurie P. | EVP, CHRO | F - Tax | $79.56 | -7,630 | 37.6K | -17% | -$607.0K |
| D | 2024-04-03 | 2024-04-01 | CVS | Havanec Laurie P. | EVP, CHRO | A - Grant | $79.56 | +9,426 | 9,426 | New | +$749.9K |
| D | 2024-04-03 | 2024-04-01 | CVS | Mandadi Tilak | EVP, CTO | A - Grant | $0.00 | +16.3K | 82.9K | +25% | $0 |
| D | 2024-04-03 | 2024-04-01 | CVS | Khichi Samrat S. | EVP, GC, CPO | A - Grant | $0.00 | +12.6K | 44.5K | +39% | $0 |
| 2024-03-01 | 2024-02-28 | CVS | COWHEY THOMAS F. | SVP, Interim CFO | F - Tax | $75.19 | -5,641 | 28.6K | -16% | -$424.1K | |
| 2024-03-01 | 2024-02-28 | CVS | Khichi Samrat S. | EVP, GC, CPO | F - Tax | $75.19 | -6,210 | 9,750 | -39% | -$466.9K | |
| 2024-03-01 | 2024-02-28 | CVS | Joyner J. David | EVP, Pres-PharmacyServices | F - Tax | $75.19 | -1,970 | 40.7K | -5% | -$148.1K | |
| 2024-02-28 | 2024-02-26 | CVS | Havanec Laurie P. | EVP, CHRO | F - Tax | $76.43 | -6,698 | 45.2K | -13% | -$511.9K | |
| 2024-02-28 | 2024-02-26 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | F - Tax | $76.43 | -261 | 43.2K | -0.6% | -$19.9K | |
| 2024-02-28 | 2024-02-26 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | F - Tax | $76.43 | -355 | 9,334 | -4% | -$27.1K | |
| 2024-02-16 | 2024-02-16 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | S - Sale | $76.95 | -29.5K | 39.8K | -43% | -$2.27M | |
| 2024-02-14 | 2024-02-12 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $0.00 | +136.6K | 136.6K | New | $0 | |
| 2024-02-14 | 2024-02-12 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | A - Grant | $0.00 | +13.3K | 69.2K | +24% | $0 | |
| 2024-02-14 | 2024-02-12 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | $0.00 | +1,926 | 8,645 | +29% | $0 | |
| 2024-02-14 | 2024-02-12 | CVS | Havanec Laurie P. | EVP, CHRO | A - Grant | $0.00 | +16.8K | 37.2K | +82% | $0 | |
| 2024-02-14 | 2024-02-12 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $0.00 | +2,452 | 7,150 | +52% | $0 | |
| 2023-12-15 | 2023-12-14 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $68.48 | -122 | 8,760 | -1% | -$8,355 | |
| 2023-12-08 | 2023-12-07 | CVS | Finucane Anne A. | Dir | G - Gift | $74.28 | -3,450 | 7,232 | -32% | -$256.3K | |
| 2023-12-01 | 2023-11-30 | CVS | COWHEY THOMAS F. | SVP, Interim CFO | A - Grant | $67.95 | +7,358 | 60.9K | +14% | +$500.0K | |
| 2023-11-17 | 2023-11-15 | CVS | Mahoney Michael F | Dir | A - Grant | $69.13 | +1,817 | 1,817 | New | +$125.6K | |
| 2023-11-17 | 2023-11-15 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $69.13 | +1,998 | 32.2K | +7% | +$138.1K | |
| 2023-11-17 | 2023-11-15 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $69.13 | +1,925 | 29.5K | +7% | +$133.1K | |
| 2023-11-17 | 2023-11-15 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $69.13 | +1,925 | 3,362 | +134% | +$133.1K | |
| 2023-11-17 | 2023-11-15 | CVS | Finucane Anne A. | Dir | A - Grant | $69.13 | +1,925 | 10.7K | +22% | +$133.1K | |
| 2023-11-17 | 2023-11-15 | CVS | Balser Jeffrey R. | Dir | A - Grant | $69.13 | +1,817 | 5,093 | +55% | +$125.6K | |
| 2023-11-17 | 2023-11-15 | CVS | KIRBY J SCOTT | Dir | A - Grant | $69.13 | +2,422 | 2,721 | +810% | +$167.4K | |
| 2023-11-06 | 2023-11-03 | CVS | LUDWIG EDWARD J | Dir | P - Purchase | $70.47 | +2,000 | 20.6K | +11% | +$140.9K | |
| 2023-10-02 | 2023-10-02 | CVS | KIRBY J SCOTT | Dir | A - Grant | $69.82 | +299 | 299 | New | +$20.9K | |
| 2023-09-01 | 2023-08-31 | CVS | Mandadi Tilak | EVP, CTO | F - Tax | $65.17 | -13.1K | 20.2K | -39% | -$850.7K | |
| 2023-09-01 | 2023-08-31 | CVS | Shah Prem S | EVP, Co-Pres of Retail | F - Tax | $65.17 | -3,508 | 51.0K | -6% | -$228.6K | |
| M | 2023-08-04 | 2023-08-03 | CVS | Clark James David | SVP, Cont, Chief Acct Off | S - Sale | $74.92 | -25.8K | 4,698 | -85% | -$1.93M |
| 2023-05-19 | 2023-05-18 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $69.31 | +1,437 | 27.6K | +5% | +$99.6K | |
| 2023-05-19 | 2023-05-18 | CVS | Balser Jeffrey R. | Dir | A - Grant | $69.31 | +1,329 | 3,276 | +68% | +$92.1K | |
| 2023-05-19 | 2023-05-18 | CVS | Finucane Anne A. | Dir | A - Grant | $69.31 | +1,437 | 8,757 | +20% | +$99.6K | |
| 2023-05-19 | 2023-05-18 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $69.31 | +1,437 | 1,437 | New | +$99.6K | |
| 2023-05-19 | 2023-05-18 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $69.31 | +1,329 | 30.2K | +5% | +$92.1K | |
| 2023-05-05 | 2023-05-03 | CVS | Lynch Karen S | Pres, CEO, Dir | P - Purchase | $69.75 | +14.0K | 431.4K | +3% | +$976.5K | |
| D | 2023-04-04 | 2023-04-01 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | F - Tax | $74.31 | -3,856 | 35.1K | -10% | -$286.5K |
| D | 2023-04-04 | 2023-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $74.31 | +2,186 | 9,080 | +32% | +$162.4K |
| D | 2023-04-04 | 2023-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $74.31 | -1,471 | 30.5K | -5% | -$109.3K |
| D | 2023-04-04 | 2023-04-01 | CVS | PELUSO MICHELLE A | EVP, Co-Pres of Retail | F - Tax | $74.31 | -98.3K | 124.4K | -44% | -$7.30M |
| D | 2023-04-04 | 2023-04-01 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | F - Tax | $74.31 | -1,854 | 6,428 | -22% | -$137.8K |
| D | 2023-04-04 | 2023-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $74.31 | -93.7K | 112.9K | -45% | -$6.96M |
| D | 2023-04-04 | 2023-04-01 | CVS | Shah Prem S | EVP, Co-Pres of Retail | F - Tax | $74.31 | -3,221 | 49.4K | -6% | -$239.4K |
| 2023-03-01 | 2023-02-27 | CVS | Havanec Laurie P. | EVP, CHRO | F - Tax | $85.77 | -4,046 | 20.4K | -17% | -$347.0K | |
| 2023-03-01 | 2023-02-28 | CVS | Khichi Samrat S. | EVP, GC, CPO | A - Grant | $83.54 | +47.9K | 47.9K | New | +$4.00M | |
| M | 2023-03-01 | 2023-02-27+ | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | F - Tax | $85.16 | -438 | 4,106 | -10% | -$37.3K |
| 2023-03-01 | 2023-02-28 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $83.54 | -179 | 26.2K | -0.7% | -$15.0K | |
| 2023-03-01 | 2023-02-27 | CVS | Shah Prem S | EVP, Co-Pres of Retail | F - Tax | $85.77 | -226 | 44.4K | -0.5% | -$19.4K | |
| 2023-03-01 | 2023-02-27 | CVS | PELUSO MICHELLE A | EVP, Co-Pres of Retail | F - Tax | $85.77 | -12.3K | 222.7K | -5% | -$1.06M | |
| 2023-03-01 | 2023-02-28 | CVS | Joyner J. David | EVP, Pres-PharmacyServices | A - Grant | $83.54 | +23.9K | 23.9K | New | +$2.00M | |
| 2023-02-03 | 2023-02-02 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $0.00 | +206.6K | 206.6K | New | $0 | |
| 2023-02-03 | 2023-02-02 | CVS | PELUSO MICHELLE A | EVP, Co-Pres of Retail | A - Grant | $0.00 | +192.6K | 207.5K | +1,291% | $0 | |
| 2023-01-04 | 2022-12-31 | CVS | Moriarty Thomas M | EVP, GC | F - Tax | $93.19 | -292.9K | 315.3K | -48% | -$27.29M | |
| DM | 2022-12-16 | 2022-12-15 | CVS | Moriarty Thomas M | EVP, GC | S - Sale+OE | $98.36 | -137.5K | 608.1K | -18% | -$13.52M |
| DM | 2022-12-16 | 2022-12-15 | CVS | Moriarty Thomas M | EVP, GC | M - OptEx | $73.85 | +137.5K | 709.1K | +24% | +$10.15M |
| 2022-12-02 | 2022-12-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $101.65 | -153 | 26.2K | -0.6% | -$15.6K | |
| 2022-12-01 | 2022-11-29 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | F - Tax | $100.88 | -442 | 2,897 | -13% | -$44.6K | |
| D | 2022-11-21 | 2022-11-17 | CVS | LUDWIG EDWARD J | Dir | A - Grant | $94.93 | +131 | 18.6K | +0.7% | +$12.4K |
| 2022-11-21 | 2022-11-17 | CVS | Balser Jeffrey R. | Dir | A - Grant | $94.93 | +1,323 | 1,947 | +212% | +$125.6K | |
| 2022-11-21 | 2022-11-17 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $94.93 | +1,402 | 26.2K | +6% | +$133.1K | |
| 2022-11-21 | 2022-11-17 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $94.93 | +1,323 | 28.8K | +5% | +$125.6K | |
| 2022-11-21 | 2022-11-17 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $94.93 | +1,402 | 2,811 | +100% | +$133.1K | |
| 2022-11-21 | 2022-11-17 | CVS | Finucane Anne A. | Dir | A - Grant | $94.93 | +1,428 | 7,320 | +24% | +$135.6K | |
| A | 2022-10-14 | 2021-12-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $88.78 | -266 | 16.7K | -2% | -$23.6K |
| 2022-09-14 | 2022-09-12 | CVS | Balser Jeffrey R. | Dir | A - Grant | $0.00 | +406 | 624 | +186% | $0 | |
| 2022-09-02 | 2022-08-31 | CVS | Mandadi Tilak | EVP, CTO | A - Grant | $0.00 | +99.8K | 99.8K | New | $0 | |
| 2022-09-02 | 2022-08-31 | CVS | Shah Prem S | EVP, Co-Pres of Retail | A - Grant | $0.00 | +20.4K | 20.4K | New | $0 | |
| 2022-09-02 | 2022-08-31 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | $0.00 | +12.7K | 12.7K | New | $0 | |
| D | 2022-08-05 | 2022-08-03 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | M - OptEx | $52.37 | +9,546 | 41.7K | +30% | +$499.9K |
| D | 2022-08-05 | 2022-08-03 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | S - Sale+OE | $100.00 | -9,546 | 32.1K | -23% | -$954.6K |
| DM | 2022-08-05 | 2022-08-03+ | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | S - Sale+OE | $98.94 | -143.4K | 109.2K | -57% | -$14.19M |
| DM | 2022-08-05 | 2022-08-03+ | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | M - OptEx | $57.49 | +143.4K | 179.6K | +397% | +$8.25M |
| A | 2022-06-30 | 2022-05-31 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | — | 0 | 0 | New | — |
| DM | 2022-06-30 | 2022-06-28 | CVS | Moriarty Thomas M | EVP, GC | M - OptEx | $61.31 | +138.7K | 675.6K | +26% | +$8.50M |
| DM | 2022-06-30 | 2022-06-28 | CVS | Moriarty Thomas M | EVP, GC | S - Sale+OE | $95.00 | -138.7K | 626.3K | -18% | -$13.17M |
| A | 2022-06-30 | 2022-05-31 | CVS | Shah Prem S | EVP, Co-Pres of Retail | A - Grant | — | 0 | 0 | New | — |
| 2022-06-06 | 2022-05-31 | CVS | Shah Prem S | EVP, Co-Pres of Retail | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 | |
| 2022-06-06 | 2022-05-31 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations